834 related articles for article (PubMed ID: 29522844)
1. Regulation of type 2 innate lymphoid cell-dependent airway hyperreactivity by butyrate.
Thio CL; Chi PY; Lai AC; Chang YJ
J Allergy Clin Immunol; 2018 Dec; 142(6):1867-1883.e12. PubMed ID: 29522844
[TBL] [Abstract][Full Text] [Related]
2. LAIR-1 acts as an immune checkpoint on activated ILC2s and regulates the induction of airway hyperreactivity.
Helou DG; Shafiei-Jahani P; Hurrell BP; Painter JD; Quach C; Howard E; Akbari O
J Allergy Clin Immunol; 2022 Jan; 149(1):223-236.e6. PubMed ID: 34144112
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase Cθ controls type 2 innate lymphoid cell and T
Madouri F; Chenuet P; Beuraud C; Fauconnier L; Marchiol T; Rouxel N; Ledru A; Gallerand M; Lombardi V; Mascarell L; Marquant Q; Apetoh L; Erard F; Le Bert M; Trovero F; Quesniaux VFJ; Ryffel B; Togbe D
J Allergy Clin Immunol; 2017 May; 139(5):1650-1666. PubMed ID: 27746240
[TBL] [Abstract][Full Text] [Related]
4. The histone deacetylase inhibitor trichostatin A suppresses murine innate allergic inflammation by blocking group 2 innate lymphoid cell (ILC2) activation.
Toki S; Goleniewska K; Reiss S; Zhou W; Newcomb DC; Bloodworth MH; Stier MT; Boyd KL; Polosukhin VV; Subramaniam S; Peebles RS
Thorax; 2016 Jul; 71(7):633-45. PubMed ID: 27071418
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-155 is a critical regulator of type 2 innate lymphoid cells and IL-33 signaling in experimental models of allergic airway inflammation.
Johansson K; Malmhäll C; Ramos-Ramírez P; Rådinger M
J Allergy Clin Immunol; 2017 Mar; 139(3):1007-1016.e9. PubMed ID: 27492144
[TBL] [Abstract][Full Text] [Related]
6. Respiratory syncytial virus prevents the subsequent development of ovalbumin-induced allergic responses by inhibiting ILC2 via the IL-33/ST2 pathway.
Wang D; Bai S; Cui Y; Zhao N; Qi F; Liu J; Zeng S; Xu L; Hu H; Liu B
Immunotherapy; 2018 Sep; 10(12):1065-1076. PubMed ID: 30027786
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of type 2 innate lymphoid cells and T
De Grove KC; Provoost S; Hendriks RW; McKenzie ANJ; Seys LJM; Kumar S; Maes T; Brusselle GG; Joos GF
J Allergy Clin Immunol; 2017 Jan; 139(1):246-257.e4. PubMed ID: 27315767
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 9-dependent interferon production prevents group 2 innate lymphoid cell-driven airway hyperreactivity.
Thio CL; Lai AC; Chi PY; Webster G; Chang YJ
J Allergy Clin Immunol; 2019 Sep; 144(3):682-697.e9. PubMed ID: 30914379
[TBL] [Abstract][Full Text] [Related]
9. Leukotriene C4 Potentiates IL-33-Induced Group 2 Innate Lymphoid Cell Activation and Lung Inflammation.
Lund SJ; Portillo A; Cavagnero K; Baum RE; Naji LH; Badrani JH; Mehta A; Croft M; Broide DH; Doherty TA
J Immunol; 2017 Aug; 199(3):1096-1104. PubMed ID: 28667163
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid receptor 2 engagement promotes group 2 innate lymphoid cell expansion and enhances airway hyperreactivity.
Hurrell BP; Helou DG; Shafiei-Jahani P; Howard E; Painter JD; Quach C; Akbari O
J Allergy Clin Immunol; 2022 May; 149(5):1628-1642.e10. PubMed ID: 34673048
[TBL] [Abstract][Full Text] [Related]
11. Distinct Roles of LFA-1 and ICAM-1 on ILC2s Control Lung Infiltration, Effector Functions, and Development of Airway Hyperreactivity.
Hurrell BP; Howard E; Galle-Treger L; Helou DG; Shafiei-Jahani P; Painter JD; Akbari O
Front Immunol; 2020; 11():542818. PubMed ID: 33193309
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin I2 Signaling and Inhibition of Group 2 Innate Lymphoid Cell Responses.
Zhou W; Toki S; Zhang J; Goleniewksa K; Newcomb DC; Cephus JY; Dulek DE; Bloodworth MH; Stier MT; Polosuhkin V; Gangula RD; Mallal SA; Broide DH; Peebles RS
Am J Respir Crit Care Med; 2016 Jan; 193(1):31-42. PubMed ID: 26378386
[TBL] [Abstract][Full Text] [Related]
13. Th2 cell-derived IL-4/IL-13 promote ILC2 accumulation in the lung by ILC2-intrinsic STAT6 signaling in mice.
Symowski C; Voehringer D
Eur J Immunol; 2019 Sep; 49(9):1421-1432. PubMed ID: 31144294
[TBL] [Abstract][Full Text] [Related]
14. Autophagy is critical for group 2 innate lymphoid cell metabolic homeostasis and effector function.
Galle-Treger L; Hurrell BP; Lewis G; Howard E; Jahani PS; Banie H; Razani B; Soroosh P; Akbari O
J Allergy Clin Immunol; 2020 Feb; 145(2):502-517.e5. PubMed ID: 31738991
[TBL] [Abstract][Full Text] [Related]
15. T cells are necessary for ILC2 activation in house dust mite-induced allergic airway inflammation in mice.
Li BW; de Bruijn MJ; Tindemans I; Lukkes M; KleinJan A; Hoogsteden HC; Hendriks RW
Eur J Immunol; 2016 Jun; 46(6):1392-403. PubMed ID: 27062360
[TBL] [Abstract][Full Text] [Related]
16. Type 2 innate lymphoid cell suppression by regulatory T cells attenuates airway hyperreactivity and requires inducible T-cell costimulator-inducible T-cell costimulator ligand interaction.
Rigas D; Lewis G; Aron JL; Wang B; Banie H; Sankaranarayanan I; Galle-Treger L; Maazi H; Lo R; Freeman GJ; Sharpe AH; Soroosh P; Akbari O
J Allergy Clin Immunol; 2017 May; 139(5):1468-1477.e2. PubMed ID: 27717665
[TBL] [Abstract][Full Text] [Related]
17. T cells and ILC2s are major effector cells in influenza-induced exacerbation of allergic airway inflammation in mice.
Li BWS; de Bruijn MJW; Lukkes M; van Nimwegen M; Bergen IM; KleinJan A; GeurtsvanKessel CH; Andeweg A; Rimmelzwaan GF; Hendriks RW
Eur J Immunol; 2019 Jan; 49(1):144-156. PubMed ID: 29762870
[TBL] [Abstract][Full Text] [Related]
18. Blocking CD226 regulates type 2 innate lymphoid cell effector function and alleviates airway hyperreactivity.
Sakano Y; Sakano K; Hurrell BP; Helou DG; Shafiei-Jahani P; Kazemi MH; Li X; Shen S; Hilser JR; Hartiala JA; Allayee H; Barbers R; Akbari O
J Allergy Clin Immunol; 2024 May; 153(5):1406-1422.e6. PubMed ID: 38244725
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E
Zhou Y; Wang W; Zhao C; Wang Y; Wu H; Sun X; Guan Y; Zhang Y
Front Immunol; 2018; 9():501. PubMed ID: 29593738
[TBL] [Abstract][Full Text] [Related]
20. Dietary Fiber-Induced Microbial Short Chain Fatty Acids Suppress ILC2-Dependent Airway Inflammation.
Lewis G; Wang B; Shafiei Jahani P; Hurrell BP; Banie H; Aleman Muench GR; Maazi H; Helou DG; Howard E; Galle-Treger L; Lo R; Santosh S; Baltus A; Bongers G; San-Mateo L; Gilliland FD; Rehan VK; Soroosh P; Akbari O
Front Immunol; 2019; 10():2051. PubMed ID: 31620118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
